Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Bristol-Myers-Squibb
Company Monitoring Page for Bristol-Myers-Squibb
latest headlines for company on cafepharma
Fierce Biotech Layoff Tracker 2023: Bayer-bought BlueRock makes cuts; Alaunos lets go 60% of teams
Fierce Biotech
Fri, 08/18/23 - 10:28 am
Tags:
layoffs
,
Alaunos Therapeutics
,
BlueRock Therapeutics
,
Thermo Fisher
,
Bristol Myers Squibb
,
Atreca
,
Galera Therapeutics
,
Inovio
,
Salarius Pharmaceuticals
,
Karyopharm Therapeutics
,
Intergalatic Therapeutics
The 10 drugs that CMS might wrangle into negotiations
Beckers Hospital Review
Wed, 08/16/23 - 10:16 am
Tags:
CMS
,
Medicare
,
drug pricing
,
Bristol Myers Squibb
,
Janssen
,
Merck
,
Pfizer
,
Amgen
,
Boehringer Ingelheim
,
Pharmacyclics
,
AstraZeneca
,
Astellas
,
GSK
Another round of layoffs hits BMS, with 100+ people impacted after earnings miss
Fierce Pharma
Mon, 08/14/23 - 11:33 am
Tags:
Bristol Myers Squibb
,
layoffs
BMS debuts ‘We Are Bristol Myers Squibb’ video
Medical Marketing and Media
Tue, 08/8/23 - 10:38 pm
Tags:
Bristol Myers Squibb
,
branding
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Mon, 08/7/23 - 10:32 am
Tags:
clinical trials
,
Sarepta Therapeutics
,
DMD
,
Elevidys
,
Bridge Bio
,
ATTR-CM
,
acoramidis
,
Sanofi
,
Merck KGaA
,
MS
,
tolebrutinib
,
Pfizer
,
obesity
,
danuglipron
,
Novo Nordisk
,
Ozempic
,
Verve Therapeutics
,
heterozygous familial hypercholesterolemia
,
Roche
,
lung cancer
,
tiragolumab
,
Vertex Pharmaceutical
,
VS-548
,
pain
,
JNJ
,
Bristol Myers Squibb
Eliquis: the cardio drug that cannot be beat
EP Vantage
Fri, 08/4/23 - 10:14 am
Tags:
Bristol Myers Squibb
,
Eliquis
,
generics
Bristol Myers, BeiGene end legacy Celgene deal with settlement years after China ban
Fierce Pharma
Thu, 08/3/23 - 11:22 am
Tags:
Bristol Myers Squibb
,
BeiGene
,
Celgene
Bristol Myers, AstraZeneca settle PD-1, CTLA-4 cancer immunotherapy patent suits for $510M
Fierce Pharma
Tue, 08/1/23 - 12:02 pm
Tags:
Bristol Myers Squibb
,
AstraZeneca
,
cancer immunotherapy
,
legal
,
patents
,
Patent Infringement
Focus: Drugmakers go under the skin, skirting early US Medicare price negotiations
Reuters
Mon, 07/31/23 - 10:12 am
Tags:
injectables
,
cancer
,
JNJ
,
Bristol Myers Squibb
,
Halozyme
,
drug pricing
BMS Reports Q2 Sales Miss Amid Generic Competition, Lowers Full-Year Guidance
BioSpace
Thu, 07/27/23 - 11:35 pm
Tags:
Bristol Myers Squibb
,
earnings
Bristol Myers gets positive opinion from CHMP for Opdivo
Pharmaceutical Business Review
Mon, 07/24/23 - 10:20 am
Tags:
Bristol Myers Squibb
,
Opdivo
,
CHMP
,
Europe
,
melanoma
Check out the most-seen pharma brand TV debuts of 2023
Medical Marketing and Media
Wed, 07/19/23 - 05:49 pm
Tags:
TV ads
,
DTC advertising
,
Bayer
,
AbbVie
,
Bristol Myers Squibb
Lilly, Novo, BMS return to boost BGV's largest European biotech fund yet
Fierce Biotech
Thu, 07/13/23 - 10:15 am
Tags:
Eli Lilly
,
Novo Holdings
,
Bristol Myers Squibb
,
venture capital
,
funding
,
BGV
,
Europe
FDA rejects Xspray's would-be rival to Bristol Myers' Sprycel on dosing, manufacturing concerns
Fierce Pharma
Wed, 07/12/23 - 09:35 am
Tags:
Xspray Pharma
,
Eversana
,
Sprycel
,
Bristol Myers Squibb
,
Dasynoc
,
leukemia
Bristol Myers' Opdivo stages comeback in bladder cancer, teeing up 2 'Merck' showdowns
Fierce Pharma
Wed, 07/12/23 - 09:30 am
Tags:
Bristol Myers Squibb
,
Opdivo
,
bladder cancer
,
Merck
BMS makes quickfire bets on neurodegeneration, paying $95M to exercise Evotec, Prothena options
Fierce Biotech
Tue, 07/11/23 - 10:13 am
Tags:
Bristol Myers Squibb
,
neurodegenerative disease
,
Prothena
,
Alzheimer's disease
,
Evotec
BMS’ Sotyktu cleared for NHS use in psoriasis
Pharmaphorum
Thu, 06/29/23 - 11:33 am
Tags:
Bristol Myers Squibb
,
Sotyktu
,
psoriasis
,
NHS
,
UK
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Wed, 06/28/23 - 11:44 am
Tags:
FDA
,
clinical trials
,
Sarepta Therapeutics
,
Bridge Bio
,
Sanofi
,
Merck KGaA
,
Pfizer
,
Novo Nordisk
,
Verve Therapeutics
,
Roche
,
Vertex Pharmaceuticals
,
JNJ
,
Bristol Myers Squibb
,
ATTR-CM
,
Elevidys
,
tolebrutinib
,
evobrutinib
,
danuglipron
,
tiragolumab
,
VX-548
,
lazertinib
BMS Follows Merck’s Lead, Sues Government Over Drug Pricing Negotiation
BioSpace
Mon, 06/19/23 - 11:41 am
Tags:
Bristol Myers Squibb
,
Merck
,
legal
,
drug pricing
,
Medicare
,
Inflation Reduction Act
CAR-T beyond cancer? Novartis and others say yes
EP Vantage
Mon, 06/19/23 - 10:19 am
Tags:
CAR-T
,
Novartis
,
Cabaletta Bio
,
Cartesian Therapeutics
,
Bristol Myers Squibb
,
Gracell
,
Yake Biotechnology
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.